Pfizer Inc.
PFE
$25.60
-$0.10-0.39%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.89% | -39.47% | 62.72% | 402.20% | 2,651.13% |
| Total Depreciation and Amortization | -28.33% | -29.48% | -26.37% | -22.92% | 5.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 268.03% | 264.08% | 130.57% | -74.77% | -62.86% |
| Change in Net Operating Assets | 89.21% | 88.10% | -60.50% | 396.32% | -164,800.00% |
| Cash from Operations | -10.17% | -3.59% | 21.27% | 97.00% | 63.08% |
| Capital Expenditure | 32.00% | 30.87% | 31.39% | 33.27% | 20.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -85.37% | -34.62% | -96.72% | -95.97% | -46.61% |
| Cash from Investing | -285.77% | -299.92% | 88.41% | 89.25% | 112.39% |
| Total Debt Issued | -19.72% | -32.74% | -95.38% | -78.83% | -81.21% |
| Total Debt Repaid | 79.66% | 66.80% | 53.00% | -8.32% | -151.40% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 23.42% | 22.98% | 23.14% | 23.28% | -2.80% |
| Other Financing Activities | 16.40% | 6.40% | 13.53% | 25.40% | 24.57% |
| Cash from Financing | 72.83% | 58.53% | -94.68% | -161.52% | -172.94% |
| Foreign Exchange rate Adjustments | 157.78% | 100.00% | 10.53% | 65.82% | 31.82% |
| Miscellaneous Cash Flow Adjustments | 300.00% | -- | -- | -166.67% | -200.00% |
| Net Change in Cash | -90.58% | 93.20% | 101.39% | 122.74% | 148.61% |